Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Biotech Licensing Viral T-Cell Immunotherapies

A company making treatments for viral infections that stimulate natural T-cells in the immune system is licensing a related technology from Baylor College of Medicine. . . . → Read More: Biotech Licensing Viral T-Cell Immunotherapies

Broad Institute in Crispr Licensing Program

One of the key inventors of a genome editing technique known as Crispr is joining a program that promises to ease licensing of its patents for the technology. . . . → Read More: Broad Institute in Crispr Licensing Program

Supreme Court Cuts Biosimilar Waiting Time

The U.S. Supreme Court ruled yesterday that makers of biologic drugs similar to branded originals need not wait an additional 6 months to begin marketing their products. . . . → Read More: Supreme Court Cuts Biosimilar Waiting Time

Engineered Immune Cells to be Explored for Solid Tumors

A cancer research center and biotechnology company will examine genetically engineered immune system cells as possible treatments for solid tumor cancers. . . . → Read More: Engineered Immune Cells to be Explored for Solid Tumors

Univ. Spin-Off Discovering New Antibiotics

A new enterprise founded by three microbiologists at Harvard Medical School is licensing the founders’ research to find treatments for antibiotic-resistant bacteria. . . . → Read More: Univ. Spin-Off Discovering New Antibiotics

Patent Awarded for COPD Dry Powder Inhaler Formula

A formulation for dry powder inhalers to treat respiratory diseases that its developers say delivers medication to the lungs more efficiently received a U.S. patent. . . . → Read More: Patent Awarded for COPD Dry Powder Inhaler Formula

Univ. Spin-Off Creating Baby Brain Development Food

A start-up enterprise spun-off from the Duke-NUS medical school in Singapore is licensing research for a new food product for mothers to help a baby’s cognitive development. . . . → Read More: Univ. Spin-Off Creating Baby Brain Development Food

$2 Billion Biotech Licensing Deal Cancelled

A licensing deal with a potential value of more than $2 billion between two biotechnology companies for a new breast cancer drug was cancelled on Friday. . . . → Read More: $2 Billion Biotech Licensing Deal Cancelled

Shire Licensing Dry Eye Disease Treatment in $535M Deal

An experimental drug for treating dry eye disease, a common disorder affecting older individuals, is being licensed by international pharmaceutical company Shire plc. . . . → Read More: Shire Licensing Dry Eye Disease Treatment in $535M Deal

Start-Up Licensing Flexible Genome-Editing Technology

A start-up biotechnology company is licensing techniques from two universities that make genome editing more flexible and better control gene expression. . . . → Read More: Start-Up Licensing Flexible Genome-Editing Technology